[Solubility of drugs as criterion for drug liberation from fat-like, galenic bases (Cetylium phthalicum, lasupol G) with reference to viscosity increasing adjuvant substances].
D000470:Alkaloids / Q000032:analysis; D000538:Aluminum Silicates / Q000494:pharmacology; D000700:Analgesics / Q000032:analysis; D000900:Anti-Bacterial Agents / Q000032:analysis; D001463:Barbiturates / Q000032:analysis; D002746:Chlorpromazine / Q000032:analysis; D003864:Depression, Chemical; D005990:Glycerol / Q000494:pharmacology; D008722:Methods; D008779:Methylthiouracil / Q000032:analysis; D010592:Pharmaceutic Aids; D004364:Pharmaceutical Preparations / Q000032:analysis*; D010783:Photometry; D011398:Promethazine / Q000032:analysis; D011804:Quinolines / Q000032:analysis; D012118:Resorcinols / Q000032:analysis; D012825:Silicon / Q000494:pharmacology*; D012822:Silicon Dioxide / Q000494:pharmacology; D012995:Solubility; D013229:Stearic Acids / Q000494:pharmacology; D013449:Sulfonamides / Q000032:analysis; D013488:Suppositories; D013566:Sympathomimetics / Q000032:analysis; D013748:Tetracaine / Q000032:analysis; D014783:Viscosity
D000470:Alkaloids; D000538:Aluminum Silicates; D000700:Analgesics; D000900:Anti-Bacterial Agents; D001463:Barbiturates; D010592:Pharmaceutic Aids; D004364:Pharmaceutical Preparations; D011804:Quinolines; D012118:Resorcinols; D013229:Stearic Acids; D013449:Sulfonamides; D013488:Suppositories; D013566:Sympathomimetics; D013748:Tetracaine; D012822:Silicon Dioxide; D011398:Promethazine; D005990:Glycerol; D008779:Methylthiouracil; D002746:Chlorpromazine; D012825:Silicon
Die Wasserlöslichkeit von Arzneimitteln als Kriterium für die Arzneistoffliberation aus fettartigen, galenischen Grundstoffen (cetylium phthalicum, Lasupol G) unter Berücksichtigung viskositätserhöhender Hilfsstoffe.